A recent study has revealed that women using hormone replacement therapy (HRT) may have a significantly lower risk of developing dementia. Tracking over 180,000 postmenopausal women in the UK, researchers found that HRT users were 10% less likely to be diagnosed with dementia and 16% less likely to develop Alzheimer’s disease compared to non-users. This finding is particularly relevant for women who have undergone surgical menopause, who showed a 26% reduction in dementia risk.
The implications of this research extend beyond individual health, potentially influencing healthcare policies regarding menopause management. As women live longer and face higher dementia risks, understanding the protective effects of HRT could reshape treatment guidelines. The study also highlights the importance of hormonal history, suggesting that women with lower lifetime oestrogen exposure may benefit more from HRT.
However, the study’s observational nature means that while associations are noted, causation cannot be confirmed. This raises questions about the broader societal impacts, including how HRT use might affect healthcare costs and the quality of life for aging women. As discussions around HRT continue, it is crucial for women to consult healthcare providers about their options.
As the research is published in a leading journal, it sets the stage for further investigations into HRT’s role in cognitive health. Future studies may clarify which forms of HRT are most effective and help establish clearer guidelines for its use in dementia prevention.
Source: The Guardian
